Vice President, M Ventures 

Hakan Goker (Ph.D.) is Vice President and responsible for healthcare investments at M Ventures, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. Hakan has been investing for the past 15 years as a partner at Aescap Venture and prior to that as part of Atlas Venture life sciences team, joining M Ventures in 2013.

Since 2006, Hakan has been instrumental in the creation, financing, and corporate strategy of multiple biotechnology companies globally including Artios, Asceneuron, Ribometrix, Storm, Bicycle, and F-star. Hakan received his PhD in cancer biology from the Institute of Cancer Research/ University of London and continued his scientific career with post-doctoral work at the Breakthrough Breast Cancer Centre/Royal Marsden Hospital.

He gained his BSc Honours, from University College London. Hakan represents M Ventures on the boards of Artios Pharma, Forendo, Ribometrix Inc., Storm Therapeutics, iOnctura, and others, and was the board member at Progyny Inc. prior to company’s public listing


20 May 2021